Mic Capital Partners (public) (us) Im, Llc - Net Worth and Insider Trading

Mic Capital Partners (public) (us) Im, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mic Capital Partners (public) (us) Im, Llc owns 1 companies in total, including Recursion Pharmaceuticals Inc (RXRX) .

Click here to see the complete history of Mic Capital Partners (public) (us) Im, Llc’s form 4 insider trades.

Insider Ownership Summary of Mic Capital Partners (public) (us) Im, Llc

Ticker	Comapny	Transaction Date	Type of Owner
RXRX	Recursion Pharmaceuticals Inc	2021-04-16	10 percent owner

Mic Capital Partners (public) (us) Im, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mic Capital Partners (public) (us) Im, Llc Ownership Network

Ownership Network List of Mic Capital Partners (public) (us) Im, Llc

No Data

Ownership Network Relation of Mic Capital Partners (public) (us) Im, Llc

Mic Capital Partners (public) (us) Im, Llc Owned Company Details

What does Recursion Pharmaceuticals Inc do?

Who are the key executives at Recursion Pharmaceuticals Inc?

Mic Capital Partners (public) (us) Im, Llc is the 10 percent owner of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include President and COO Tina Marriott Larson , Chief Financial Officer Michael Secora , and director & 10 percent owner & Chief Executive Officer Christopher Gibson .

Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary

Over the past 18 months, Mic Capital Partners (public) (us) Im, Llc made no insider transaction in Recursion Pharmaceuticals Inc (RXRX). Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 496,133 shares made by Blake Borgeson , a net sale of 1,209,278 shares made by Christopher Gibson , and a net sale of 94,000 shares made by Tina Marriott Larson .

In summary, during the past 3 months, insiders sold 256,682 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 256,682 shares. During the past 18 months, 2,974,541 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,974,541 shares.

Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Recursion Pharmaceuticals Inc Insider Transactions

No Available Data

Mic Capital Partners (public) (us) Im, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Mic Capital Partners (public) (us) Im, Llc. You might contact Mic Capital Partners (public) (us) Im, Llc via mailing address: Al Sila Tower, 22nd Floor, Adgm Square, Al Maryah Island Abu Dhabi C0 00000.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.